The MRFF 2026 BioMedTech Incubator Program provides grants of financial assistance to support medical research and medical innovation projects through the establishment of BioMedTech Incubators.

The 2026 BioMedTech Grant Opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative.

This opportunity looks to fund suitable organisations to identify, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects that have commercial potential.

The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by increasing the number of SMEs developing novel biomarkers, diagnostics, therapeutics, assistive devices and/or digital technologies that have progressed through the early stages of research and development to the point where they are 'de-risked' and attractive to private investment for commercialisation.

Applicants may propose to support development of innovations in their area/s of strength (i.e. applicants are not required to propose a program that covers the breadth of the biomedtech sector).

To be eligible you must:

• have an Australian Business Number (ABN) be incorporated in Australia and in accordance with s24 of the MRFF Act 20151 ,
• be one of the following entities:
  • a medical research institute
  • a university
  • a corporate Commonwealth entity
  • a corporation (including businesses and not for profits).

Joint applications are encouraged, provided you have a lead organisation who is the main driver of the project and is eligible to apply. For further information on joint applications, refer to section .2.

They cannot waive the eligibility criteria under any circumstances.

• Phone: 13 28 46
• Email: BMTI@industry.gov.au